DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA)

CAPS Rating: 4 out of 5

A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.

Recs

0
Player Avatar 1badbeerad (34.97) Submitted: 10/2/2012 12:19:40 PM : Outperform Start Price: $6.81 DUSA Score: -4.69

Rocket in the pocket.

Featured Broker Partners


Advertisement